SCHEMBL20133364

SCHEMBL20133364

Oc1ccc(COCc2ccccc2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
LMNA P02545 3/20 0.47
CYP1A2 P05177 1/20 0.47
PTGS1 P23219 1/20 0.47
SLC6A2 P23975 1/20 0.47
CYP2C19 P33261 1/20 0.47
PTGS2 P35354 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HIF1A Q16665 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.43
KDM4E B2RXH2 3/20 0.43
DEGS1 O15121 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
POLB P06746 2/20 0.42
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31224617 0.81 TSHR (0.52) TSHRL3MBTL1KDM4ENPC1RAB9A
SCHEMBL2421993 0.80 NR4A2 (0.53) TSHRMAPTEGLN1P4HTM
SCHEMBL1602934 0.79 ESR1 (0.47) LMNACYP1A2PTGS1SLC6A2CYP2C19
Hydroquinone SCHEMBL51561 0.78 TSHR (0.79) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL9519559 0.78 P4HTM (0.49) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL13279444 0.77 AR (0.40)
SCHEMBL1840533 0.76 TSHR (0.75) TSHRLMNACYP1A2PTGS1SLC6A2
Hydroquinone SCHEMBL7511716 0.76 TSHR (0.75) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL9673277 0.76 TSHR (0.60) TSHRLMNACYP1A2L3MBTL1KDM4E
Hydrogen Peroxide SCHEMBL28758135 0.76 TSHR (0.94) TSHRLMNACYP1A2PTGS1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE CRBN, VHL, UBQLN2 TSHR 3954/4885LMNA 1476/4885CYP1A2 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.